Search results
Results from the WOW.Com Content Network
The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis ...
Teva has to cooperate with the agency's demand by July 24, the report said. ... -The U.S. Federal Trade Commission has opened an investigation into Teva Pharmaceutical over the company's refusal ...
The announcement came a day after the city reached an $80 million settlement over opioids with drugmaker Teva Pharmaceutical. Baltimore did not disclose the terms of its settlement with Walgreens ...
Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs , but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing ...
The case originated in the Southern District of New York, where Sandoz sued to invalidate Teva's patent on a drug for the treatment of multiple sclerosis.In the Markman hearing, Sandoz argued that a claim was fatally indefinite for failing to identify which of three possible meanings a particular claim term, related to the molecular weight of a component of the drug, should be interpreted to have.
Teva Canada launched Novo-Sildenafil, a generic version of Viagra, on the day the Supreme Court of Canada released its decision. [ 5 ] [ 21 ] [ 22 ] On August 5, 2014, the Supreme Court of British Columbia certified a class action against Pfizer.
Teva and its subsidiary Cephalon were fined 60.5 million euros ($66.7 million) in 2020 for agreeing to delay a cheaper generic version of Cephalon's sleep disorder medicine, part of the EU's ...
Teva Pharmaceuticals is feverishly working to deflect revenue risk tied to the impending patent expiration for its highly popular multiple sclerosis drug Copaxone. The company's attempts to block ...